JP2011087587A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011087587A5 JP2011087587A5 JP2010263015A JP2010263015A JP2011087587A5 JP 2011087587 A5 JP2011087587 A5 JP 2011087587A5 JP 2010263015 A JP2010263015 A JP 2010263015A JP 2010263015 A JP2010263015 A JP 2010263015A JP 2011087587 A5 JP2011087587 A5 JP 2011087587A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16483599P | 1999-11-12 | 1999-11-12 | |
| US22114200P | 2000-07-27 | 2000-07-27 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001537340A Division JP5583308B2 (en) | 1999-11-12 | 2000-11-08 | 21 human secreted proteins |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013141728A Division JP2013233148A (en) | 1999-11-12 | 2013-07-05 | 21 human secreted proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011087587A JP2011087587A (en) | 2011-05-06 |
| JP2011087587A5 true JP2011087587A5 (en) | 2012-01-12 |
Family
ID=26860899
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001537340A Expired - Fee Related JP5583308B2 (en) | 1999-11-12 | 2000-11-08 | 21 human secreted proteins |
| JP2010263015A Pending JP2011087587A (en) | 1999-11-12 | 2010-11-25 | 21 human secreted proteins |
| JP2013141728A Pending JP2013233148A (en) | 1999-11-12 | 2013-07-05 | 21 human secreted proteins |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001537340A Expired - Fee Related JP5583308B2 (en) | 1999-11-12 | 2000-11-08 | 21 human secreted proteins |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013141728A Pending JP2013233148A (en) | 1999-11-12 | 2013-07-05 | 21 human secreted proteins |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1244683A4 (en) |
| JP (3) | JP5583308B2 (en) |
| AU (1) | AU1473501A (en) |
| CA (1) | CA2387959A1 (en) |
| WO (1) | WO2001034629A1 (en) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7202342B1 (en) | 1999-11-12 | 2007-04-10 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US7517952B1 (en) | 1997-02-25 | 2009-04-14 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US20030185830A1 (en) | 1997-02-25 | 2003-10-02 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US7264926B2 (en) | 2000-04-18 | 2007-09-04 | Millennium Pharmaceuticals, Inc. | Nucleoside Phosphatase |
| US7030219B2 (en) * | 2000-04-28 | 2006-04-18 | Johns Hopkins University | B7-DC, Dendritic cell co-stimulatory molecules |
| US20030031675A1 (en) | 2000-06-06 | 2003-02-13 | Mikesell Glen E. | B7-related nucleic acids and polypeptides useful for immunomodulation |
| EP1892251A3 (en) * | 2000-06-06 | 2008-12-31 | Brystol-Myers Squibb Company | B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| EP1292619B1 (en) | 2000-06-06 | 2008-02-06 | Bristol-Myers Squibb Company | B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| EP1320599A2 (en) | 2000-06-28 | 2003-06-25 | Genetics Institute, LLC | Pd-l2 molecules: pd-1 ligands and uses therefor |
| WO2002006326A2 (en) * | 2000-07-14 | 2002-01-24 | Millennium Pharmaceuticals, Inc. | 62088, a human nucleoside phosphatase family member and uses thereof |
| US6635750B1 (en) | 2000-07-20 | 2003-10-21 | Millennium Pharmaceuticals, Inc. | B7-H2 nucleic acids, members of the B7 family |
| AU2001291087A1 (en) * | 2000-09-20 | 2002-04-02 | Amgen Inc. | B7-like molecules and uses thereof |
| AU2006202524B2 (en) * | 2000-09-20 | 2009-12-03 | Amgen, Inc. | B7-Like Molecules and Uses Thereof |
| US7048931B1 (en) | 2000-11-09 | 2006-05-23 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| WO2002052007A1 (en) * | 2000-12-22 | 2002-07-04 | Locomogene, Inc. | Synovial membrane cell protein |
| DE10215601B4 (en) | 2002-04-10 | 2005-08-04 | Henkel Kgaa | Water-soluble container and process for its preparation and use |
| JPWO2005016367A1 (en) * | 2003-08-13 | 2006-10-12 | 株式会社ロコモジェン | Preparations for the treatment of hematopoietic diseases |
| HUE039237T2 (en) | 2004-10-06 | 2018-12-28 | Mayo Found Medical Education & Res | B7-h1 and pd-1 in treatment of renal cell carcinoma |
| AU2006254902B8 (en) | 2005-06-08 | 2012-08-16 | Dana-Farber Cancer Institute, Inc. | Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway |
| CA2744449C (en) | 2008-11-28 | 2019-01-29 | Emory University | Methods for the treatment of infections and tumors |
| KR20210060670A (en) | 2008-12-09 | 2021-05-26 | 제넨테크, 인크. | Anti-pd-l1 antibodies and their use to enhance t-cell function |
| WO2013073968A2 (en) * | 2011-09-12 | 2013-05-23 | Industrial Research Limited | Agents for modulation of cell signalling |
| US9302005B2 (en) | 2013-03-14 | 2016-04-05 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
| ES2714708T3 (en) | 2013-10-01 | 2019-05-29 | Mayo Found Medical Education & Res | Procedures for the treatment of cancer in patients with elevated levels of Bim |
| US10302653B2 (en) | 2014-05-22 | 2019-05-28 | Mayo Foundation For Medical Education And Research | Distinguishing antagonistic and agonistic anti B7-H1 antibodies |
| US10517875B2 (en) | 2014-07-23 | 2019-12-31 | Mayo Foundation for Medical Engineering and Research | Targeting DNA-PKcs and B7-H1 to treat cancer |
| WO2017075045A2 (en) | 2015-10-30 | 2017-05-04 | Mayo Foundation For Medical Education And Research | Antibodies to b7-h1 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5707829A (en) * | 1995-08-11 | 1998-01-13 | Genetics Institute, Inc. | DNA sequences and secreted proteins encoded thereby |
| ES2242966T3 (en) * | 1995-07-19 | 2005-11-16 | Genetics Institute, Llc | CTLA-8HUMANA AND USES OF PROTEINS RELATED TO CTLA-8. |
| US5807703A (en) * | 1996-06-17 | 1998-09-15 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| US5831056A (en) * | 1996-06-07 | 1998-11-03 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| AU8504098A (en) | 1997-07-22 | 1999-02-16 | University Of Maryland | Methods of modifying the butyrophilin protein to eliminate an autoimmune response and products associated therewith |
| AU3899700A (en) * | 1999-03-17 | 2000-10-04 | Alphagene, Inc. | Secreted proteins and polynucleotides encoding them |
| EP1074617A3 (en) * | 1999-07-29 | 2004-04-21 | Research Association for Biotechnology | Primers for synthesising full-length cDNA and their use |
| JP2002191363A (en) * | 1999-07-29 | 2002-07-09 | Herikkusu Kenkyusho:Kk | PRIMER FOR WHOLE LENGTH cDNA SYNTHESIS AND ITS USE |
-
2000
- 2000-11-08 EP EP00977043A patent/EP1244683A4/en not_active Withdrawn
- 2000-11-08 CA CA002387959A patent/CA2387959A1/en not_active Abandoned
- 2000-11-08 JP JP2001537340A patent/JP5583308B2/en not_active Expired - Fee Related
- 2000-11-08 WO PCT/US2000/030654 patent/WO2001034629A1/en active Application Filing
- 2000-11-08 AU AU14735/01A patent/AU1473501A/en not_active Abandoned
-
2010
- 2010-11-25 JP JP2010263015A patent/JP2011087587A/en active Pending
-
2013
- 2013-07-05 JP JP2013141728A patent/JP2013233148A/en active Pending